NCT03801239

Brief Summary

The aim of this study was to develop and assess the effectiveness of a Polish version of OABSS and to correlate the OABSS with urodynamic study results and UDI-6, IIQ-7 questionnaires

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
822

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

January 9, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 11, 2019

Completed
Last Updated

January 11, 2019

Status Verified

January 1, 2019

Enrollment Period

1.6 years

First QC Date

January 9, 2019

Last Update Submit

January 9, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation of OABSS questionnaire and Urodynamic study

    Results of polish version of OABSS are correlated with Urodynamic study results

    2 weeks

Secondary Outcomes (2)

  • Correlation of OABSS questionnaire with UDI-6 results

    2 weeks

  • Correlation of OABSS questionnaire with IIQ-7 results

    2 weeks

Study Arms (3)

patients with Overactive Bladder (OAB)

Patients completed the Polish version of the OABSS on two separate visits: Week 0 and Week 2 and additionally UDI-6, IIQ-7 during visit- Week 2.

Diagnostic Test: Urodynamic StudyDiagnostic Test: OABSS questionnaire fulfilmentDiagnostic Test: UDI-6 questionnaire fulfilmentDiagnostic Test: IIQ-7 questionnaire fulfilment

patients with Mixed Urinary incontinence (MUI)

Patients completed the Polish version of the OABSS on two separate visits: Week 0 and Week 2 and additionally UDI-6, IIQ-7 during visit- Week 2.

Diagnostic Test: Urodynamic StudyDiagnostic Test: OABSS questionnaire fulfilmentDiagnostic Test: UDI-6 questionnaire fulfilmentDiagnostic Test: IIQ-7 questionnaire fulfilment

patients with Stress Urinary Incontinence (SUI)

Patients completed the Polish version of the OABSS on two separate visits: Week 0 and Week 2 and additionally UDI-6, IIQ-7 during visit- Week 2.

Diagnostic Test: Urodynamic StudyDiagnostic Test: OABSS questionnaire fulfilmentDiagnostic Test: UDI-6 questionnaire fulfilmentDiagnostic Test: IIQ-7 questionnaire fulfilment

Interventions

Urodynamic StudyDIAGNOSTIC_TEST

during visit Week 0 patients had urodynamic study

patients with Mixed Urinary incontinence (MUI)patients with Overactive Bladder (OAB)patients with Stress Urinary Incontinence (SUI)

during visit Week 0 and Week 2 patients fulfilled OABSS

patients with Mixed Urinary incontinence (MUI)patients with Overactive Bladder (OAB)patients with Stress Urinary Incontinence (SUI)

during visit Week 2 patients fulfilled UDI-6 questionnaire

patients with Mixed Urinary incontinence (MUI)patients with Overactive Bladder (OAB)patients with Stress Urinary Incontinence (SUI)

during visit Week 2 patients fulfilled IIQ-7 questionnaire

patients with Mixed Urinary incontinence (MUI)patients with Overactive Bladder (OAB)patients with Stress Urinary Incontinence (SUI)

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients were recruited from women attending the Outpatient Clinic of the 2nd Gynecology Department of the Medical University in Lublin. SUI was observed in 290 cases; OAB in 283 patients and 249 had MUI

You may qualify if:

  • confirmed Urinary Incontinence in Urodynamic study (SUI, OAB, MUI)
  • female aged 18-75 years old

You may not qualify if:

  • malignant disorders
  • uncontrolled diabetes
  • inability to understand informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Lublin

Lublin, Lublin Voivodeship, 20-954, Poland

Location

MeSH Terms

Conditions

Urinary Bladder, OveractiveUrinary Incontinence

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsUrination Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, MD associated professor

Study Record Dates

First Submitted

January 9, 2019

First Posted

January 11, 2019

Study Start

June 1, 2017

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

January 11, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations